Introduction: Clinical pharmacists are well positioned to enhance efforts to promote emergency department (ED)-initiated buprenorphine to treat opioid use disorder (OUD). Among clinical pharmacists in urban EDs, we sought to characterize barriers and facilitators for ED-initiated buprenorphine to inform future implementation efforts and enhance access to this highly effective OUD treatment.
Methods: This study was conducted as a part of Project ED Health (CTN-0069, NCT03023930), a multisite effectiveness-implementation study aimed at promoting ED-initiated buprenorphine that was conducted between April 2017 and July 2020. Data collection and analysis were grounded in the Promoting Action on Research Implementation in Health Services (PARIHS) framework to assess perspectives on the relationship between 3 elements: evidence for buprenorphine, the ED context, and facilitation needs to promote ED-initiated buprenorphine. The study used an iterative coding process to identify overlapping themes within these 3 domains.
Results: The study conducted eight focus groups/interviews across four geographically disparate EDs with 15 pharmacist participants. We identified six themes. Themes related to evidence included (1) varied levels of comfort and experience among pharmacists with ED-initiated buprenorphine that increased over time and (2) a perception that patients with OUD have unique challenges that require guidance to optimize ED care. With regards to context, clinical pharmacists identified: (3) their ability to clarify scope of ED care in the context of unique pharmacology, formulations, and regulations of buprenorphine to ED staff, and that (4) their presence promotes successful program implementation and quality improvement. Participants identified facilitation needs including: (5) training to promote practice change and (6) ways to leverage already existing pharmacy resources outside of the ED.
Conclusion: Clinical pharmacists play a unique and critical role in the efforts to promote ED-initiated buprenorphine. We identified 6 themes that can inform pharmacist-specific interventions that could aid in the successful implementation of this practice.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.josat.2023.209058 | DOI Listing |
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11654915 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Initiation of buprenorphine in the emergency department or emergency out-of-hospital setting: A mixed-methods systematic review.
Am J Emerg Med
November 2024
Department of Paramedicine, School of Primary and Allied Health Care, Faculty of Medicine, Nursing, and Health Sciences, Monash University, Victoria, Australia.
Introduction: People who use substances increasingly access healthcare primarily through emergency medical services (EMS) and emergency departments (EDs). To meet the needs of these patients, EMS and EDs have become access points for medications for opioid use disorder (OUD), specifically buprenorphine. This systematic review aimed to quantify the efficacy of these programs, examining retention in treatment for OUD, rates of re-presentation to ED or EMS, and rates of precipitated withdrawal, as well as summarise clinician and patient perspectives on buprenorphine initiation in these settings.
View Article and Find Full Text PDFCost-Effectiveness of Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder.
Ann Emerg Med
November 2024
Department of Population Health Sciences, Weill Cornell Medicine, New York, NY; Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH), Weill Cornell Medicine, New York, NY. Electronic address:
Article Synopsis
- This study aimed to assess whether a method called implementation facilitation is more cost-effective than traditional educational strategies in promoting the use of buprenorphine for opioid use disorder in emergency departments (EDs).
- Researchers conducted a cost-effectiveness analysis during "Project ED Health," measuring outcomes like quality-adjusted life-years and patient engagement with community care, and found that while the costs were similar, the facilitation method led to significantly better effectiveness.
- The results indicated a 74% to 75% chance that implementation facilitation is considered cost-effective within typical health care spending thresholds, suggesting it could be a viable approach to improve opioid treatment outcomes.
Buprenorphine Administration and Prescribing at Emergency Departments: A National Analysis from 2014-2021.
J Addict Med
November 2024
From the Department of Emergency Medicine, Rutgers New Jersey Medical School, Newark, NJ (CR, LSN); Georgetown University School of Medicine, Washington, DC (TMcG, MM-A); Department of Emergency Medicine, MedStar Washington Hospital Center, Washington, DC (M-MA); and Department of Emergency Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA (JP).
Article Synopsis
- This study reviews trends in buprenorphine use in emergency departments (EDs) from 2014 to 2021 to understand its role in reducing opioid overdose risks and improving treatment access.
- There were nearly 342,000 ED visits with administered buprenorphine, showing no significant change over time, but a notable increase (233%) in buprenorphine prescriptions at discharge between 2019 and 2020.
- The findings suggest EDs served as crucial support for addiction treatment during the COVID-19 pandemic, highlighting a need for further research on the barriers to buprenorphine use.
Evaluation of an emergency department-based approach to reduce subsequent opioid overdoses.
J Am Coll Emerg Physicians Open
October 2024
Objective: The purpose of this study was to determine the association of a multi-pronged treatment program in emergency department (ED) patients with an acute presentation of opioid use disorder (OUD) on the rate of subsequent opioid overdose (OD). This approach included ED-initiated take-home naloxone, prescription buprenorphine, and an ED-based peer support and recovery program.
Methods: This was a retrospective observational analysis of adult patients presenting to the ED at a large urban hospital system from November 1, 2017 to March 17, 2023.
Facilitators of and barriers to buprenorphine initiation in the emergency department: a scoping review.
Lancet Reg Health Am
October 2024
Department of Psychiatry, University of Toronto, 250 College Street, Toronto, Ontario, Canada.
Article Synopsis
- * The study reviews various challenges and supports for starting buprenorphine treatment in the ED, highlighting the importance of teams and accessible services while pointing out issues like stigma and the complex needs of patients.
- * There's a call for better coordination in these efforts and the inclusion of diverse perspectives to create fairer pathways for starting opioid treatment in both the U.S. and Canada.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!